Nexium (Esomeprazole Magnesium Trihydrate)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, and ulcer‑related disorders.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers, ensuring consistent product availability across diverse markets.

Nexium (esomeprazole) acts on the gastric proton pump pathway to lower stomach acidity in several gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH. - Erosive esophagitis: promotes healing of inflamed esophageal tissue and prevents further damage. - NSAID‑induced gastric ulcer: protects the gastric lining and facilitates ulcer resolution. - Helicobacter pylori eradication (as part of combination therapy): enhances the effectiveness of antibiotics by reducing acid‑mediated bacterial survival. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Esomeprazole may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild pain often resolving without treatment. - Diarrhoea: loose stools that may be transient. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort in the stomach region.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Low magnesium levels: can lead to muscle cramps or cardiac arrhythmia. - Bone fracture risk: long‑term use may affect calcium absorption.

Before prescribing Nexium, clinicians should consider several precautionary measures to ensure patient safety. - Assess renal function: dose adjustment may be needed in impaired kidneys. - Monitor magnesium levels: prolonged therapy can cause hypomagnesemia. - Evaluate liver disease: use with caution in hepatic impairment. - Use cautiously in the elderly: increased risk of fractures and infections. - Limit duration of therapy: re‑evaluate necessity after several weeks. - Store at room temperature: keep in the original container, protect from moisture.

Esomeprazole can affect the plasma concentrations of several concomitant medications, requiring attention to interaction potential.

Major Interactions (Avoid): - Ketoconazole: reduced absorption leading to therapeutic failure. - Atazanavir: decreased antiviral efficacy due to increased gastric pH. - Clopidogrel: diminished antiplatelet effect increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels may cause toxicity. - Methotrexate: reduced clearance can raise toxicity risk. - Calcium carbonate: may decrease esomeprazole absorption if taken simultaneously. - Warfarin: possible alteration in anticoagulant effect; monitor INR.